As the second quarter gets underway, April stands out for both global health awareness - from Cancer Control Month to World Health Day on April 7 - and a fresh wave of regulatory catalysts. Here's a look at the upcoming FDA decisions scheduled for April.
Biogen Inc. (BIIB)
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com